Evidence map›Paper›PMID 23795739›Full record

ArticleHigh altitude medicine & biology2013

Intermittent hypobaric hypoxia promotes atherosclerotic plaque instability in ApoE-deficient mice.

Sihua Jiang, Feipeng Jin, De Li, Xingmei Zhang, Yun Yang, Dachun Yang, Kun Li, Yongjian Yang, Shuangtao Ma

Abstract readEvaluation Study
In one paragraph

Article in High altitude medicine & biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Hypoxemia as a model for high altitude and cardiovascular risk reduction.Journal of molecular medicine (Berlin, Germany) · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sihua JiangDepartment of Cardiology, General Hospital of PLA Chengdu Military Area Command, Chengdu, People's Republic of China.
Feipeng Jin
De Li
Xingmei Zhang
Yun Yang
Dachun Yang
Kun Li
Yongjian Yang
Shuangtao Ma

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimSudden cardiac death is one of the most frequent causes of death at high altitude. It has been reported that the intermittent normobaric hypoxia experienced by patients with obstructive sleep apnea may enhance the development of atherosclerosis. However, the effect of hypobaric hypoxia, which mimics the ambient air at high altitude, in the development of atherosclerosis has not been investigated.

methodsTwenty male ApoE-deficient mice, 8 weeks of age, were subjected to either control conditions or intermittent hypobaric hypoxia (IHH) for 8 weeks. Mice in the IHH group were exposed to a hypobaric chamber that replicated the hypobaric hypoxia conditions found at 4000 m altitude for 8 hours a day.

resultsIHH-exposed mice did not significantly differ from control mice in plasma lipid levels, including triglyceride, total cholesterol, low-density lipoprotein, and high-density lipoprotein. The hematoxylin and eosin-stained sections of the aortic root showed similar plaque size between the groups. However, IHH-treated mice exhibited significantly decreased plaque collagen content, a feature of atherosclerotic plaque stability. Additionally, matrix metalloproteinase (MMP)-9 protein expression was significantly increased, whereas tissue inhibitor of MMP (TIMP)-2 expression was decreased after exposure to IHH.

conclusionIHH may promote atherosclerotic plaque instability in ApoE-deficient mice by changing the balance of MMPs and TIMPs.

Indexed as

AltitudeAir PressureAnimalsApolipoproteins EBiomarkersCollagenHypoxiaImmunohistochemistryLipidsMaleMiceMice, KnockoutPlaque, AtheroscleroticRandom AllocationApolipoproteins EBiomarkersCollagenLipids

Identifiers

PMID23795739
PMCPMC3694515

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.